NCT00089921View on ClinicalTrials.gov

SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate

PHASE2CompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

October 31, 2005

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

SCIO-469

60 mg capsule three times daily for 12 weeks

DRUG

SCIO-469

30 mg capsule three times daily for 12 weeks

DRUG

Placebo

2 capsules three times daily and one tablet daily

DRUG

SCIO-469

100 mg tablet once daily for 12 weeks

All Listed Sponsors
lead

Scios, Inc.

INDUSTRY

NCT00089921 - SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate | Biotech Hunter | Biotech Hunter